Presentation is loading. Please wait.

Presentation is loading. Please wait.

Cymatherapy ® Homeodynamics Perfusion Thermography Preliminary Investigations Perfusion Thermography Preliminary Investigations Copyright  2006 Elizabeth.

Similar presentations


Presentation on theme: "Cymatherapy ® Homeodynamics Perfusion Thermography Preliminary Investigations Perfusion Thermography Preliminary Investigations Copyright  2006 Elizabeth."— Presentation transcript:

1 Cymatherapy ® Homeodynamics Perfusion Thermography Preliminary Investigations Perfusion Thermography Preliminary Investigations Copyright  2006 Elizabeth Bauer. All Rights Reserved.

2 Cymatherapy ® Perfusion Thermography: Preliminary Investigation Thermography, a type of infrared imaging, detects radiation in the infrared range of the electromagnetic spectrum (roughly 900–14,000 nanometers) producing images of that radiation. As a noninvasive bioinstrument it measures vasoactive peripheral perfusion.

3 Infrared Range of the Electromagnetic Spectrum

4 Perfusion is the delivery of arterial blood that supplies nutrients and oxygen to capillary beds in biological tissue. Cymatherapy ® Perfusion Thermography Animation: Perfusion of the myocardium, NHLBI Research at Bethesda. IschemiaNormal Perfusion

5 Animation: Looking into a coronary artery. Cymatherapy ® Perfusion Thermography: Preliminary Investigation

6 Adequate blood supply is vital to the health of all cells and organ systems and essential for sustaining life. The function of the circulatory system is to deliver oxygen and nutrients to all cells. It also removes carbon dioxide and waste products maintaining optimal tissue pH. Adequate blood supply is vital to the health of all cells and organ systems and essential for sustaining life. The function of the circulatory system is to deliver oxygen and nutrients to all cells. It also removes carbon dioxide and waste products maintaining optimal tissue pH. Ischemia

7 Without viable perfusion, organ systems suffer; the sequeli of ischemic cascade and cellular degradation ensues, thus life ends. Since oxygen is mainly bound to hemoglobin in red blood cells, insufficient blood supply causes tissue to become hypoxic, or, if no oxygen is supplied at all, anoxic. Anoxia can cause necrosis (cell death). Without viable perfusion, organ systems suffer; the sequeli of ischemic cascade and cellular degradation ensues, thus life ends. Since oxygen is mainly bound to hemoglobin in red blood cells, insufficient blood supply causes tissue to become hypoxic, or, if no oxygen is supplied at all, anoxic. Anoxia can cause necrosis (cell death). Ischemia

8 When perfusion is impeded, the eschemic cascade ensues within seconds to minutes, necrosis due to ischemia usually takes about hours.

9 The The goal of this preliminary investigation was to study the value of the code for Artery Support, in increasing arterial flow to the areas of Cymatherapy ® application. With the successful results of this random control (normal) group it was decided that experimental groups should also be studied. Animation: Perfusion (arterial blood flow), University of Liverpool. Cymatherapy ® Perfusion Thermography:

10 The following slides show a preliminary investigation of a random control group. Thermographs were obtained before and after administering the code for Artery Support, for 10 minutes to both forearms in supination (an area from the wrist to the elbow with palm side up.) Cymatherapy ® Perfusion Thermography: Preliminary Investigation

11 Before Cymatherapy ® After Cymatherapy ® Cymatherapy ® Perfusion Thermography: Preliminary Investigation

12 Before Cymatherapy ® After Cymatherapy ® Cymatherapy ® Perfusion Thermography: Preliminary Investigation

13 Before Cymatherapy ® After Cymatherapy ® Cymatherapy ® Perfusion Thermography: Preliminary Investigation

14 Before Cymatherapy ® After Cymatherapy ® Three Hours After Cymatherapy ® Cymatherapy ® Perfusion Thermography: Preliminary Investigation

15 Before Cymatherapy ® After Cymatherapy ® Cymatherapy ® Perfusion Thermography: Preliminary Investigation

16 Before Cymatherapy ® After Cymatherapy ® Cymatherapy ® Perfusion Thermography: Preliminary Investigation

17 Before Cymatherapy ® After Cymatherapy ® Cymatherapy ® Perfusion Thermography: Preliminary Investigation

18 Before Cymatherapy ® After Cymatherapy ® Cymatherapy ® Perfusion Thermography: Preliminary Investigation

19 Before Cymatherapy ® After Cymatherapy ® Cymatherapy ® Perfusion Thermography: Preliminary Investigation

20 Cymatherapy ® Perfusion Thermography Preliminary Investigation: Control Group Summary The previous slides did show an increase in perfusion to the areas of application of Cymatherapy. Surprisingly, increased perfusion to sites distal to the site of application were also seen.

21 The following slides show a preliminary study of a random control group. Thermographs were obtained before and after administering the code for Artery Support for 10 minutes to the back. Cymatherapy ® Perfusion Thermography: Preliminary Investigation

22 Before Cymatherapy ® After Cymatherapy ® Cymatherapy ® Perfusion Thermography: Preliminary Investigation

23 Before Cymatherapy ® After Cymatherapy ® Cymatherapy ® Perfusion Thermography: Preliminary Investigation

24 Before Cymatherapy ® After Cymatherapy ® Cymatherapy ® Perfusion Thermography: Preliminary Investigation

25 Before Cymatherapy ® After Cymatherapy ® Cymatherapy ® Perfusion Thermography: Preliminary Investigation

26 The following slides show a preliminary investigation of pulmonary issues. Thermographs were obtained before and after administering Cymatherapy ® to the back. This investigation still continues. Cymatherapy ® Perfusion Thermography: Preliminary Investigation

27 Cymatherapy ® Perfusion Thermography: Emphysema Before Cymatherapy ® After Cymatherapy ®

28 Cymatherapy ® Perfusion Thermography: Pulmonary Fibrosis Before Cymatherapy ® After One Session After Four Sessions

29 The following slides show a preliminary investigation of perfusion of the legs and feet. Thermographs were obtained before and after administering Cymatherapy ® to the feet. Cymatherapy ® Perfusion Thermography: Preliminary Investigation

30 Before Cymatherapy ® After Cymatherapy ® Cymatherapy ® Perfusion Thermography: Normal Feet

31 Cymatherapy ® Perfusion Thermography: Normal Legs and Feet Before Cymatherapy ® After Cymatherapy ®

32 Cymatherapy ® Thermography: Neuritis due to Peripheral Neuropathy Before Cymatherapy ® After Cymatherapy ® Cymatherapy ® was administered ONLY to the feet.

33 Before Cymatherapy ® After Cymatherapy ® Cymatherapy ® to the Inflammation of Peripheral Vascular Disease Legs Inflammation Decreased

34 Cymatherapy ® to the Inflammation of Peripheral Vascular Disease Before Cymatherapy ® After Cymatherapy ® Feet Inflammation Decreased Perfusion Increased No Palpable Pulses Palpable Pulses Restored

35 Cymatherapy ® Perfusion Thermography Preliminary Investigation: Summary Cymatherapy ® Perfusion Thermography Preliminary Investigation: Summary The results of these preliminary investigations were very promising. Objective improvements were shown in the control groups: both subjective and objective improvements as well as functional outcomes were shown in the experimental groups. These very promising results warrant further study. The results of these preliminary investigations were very promising. Objective improvements were shown in the control groups: both subjective and objective improvements as well as functional outcomes were shown in the experimental groups. These very promising results warrant further study.

36 The results of these preliminary investigation are being published: Fleming AHJ, presenter Bauer EB, primary investigator Acoustic/magnetic Field Perfusion Study 2nd International Conference on Electromagnetic Fields, Health and Environment (EHE); Wroclaw, Poland, September 10-12, In press. The results of these preliminary investigation are being published: Fleming AHJ, presenter Bauer EB, primary investigator Acoustic/magnetic Field Perfusion Study 2nd International Conference on Electromagnetic Fields, Health and Environment (EHE); Wroclaw, Poland, September 10-12, In press.

37 Cymatherapy ® Would like to Thank… Marie Dahle and John Enge for all of their efforts, advice and assistance in this project. Rebecca Moss for her patience and Thermography work. The entire staff of the: Covenant Health Clinic for their assistance, patience, hospitality and kindness. Cymatherapy ® for a Kinder Answer Dr. Rhett Bergeron

38 Copyright  2006 Elizabeth Bauer. All Rights Reserved. Cymatherapy ® Homeodynamics Perfusion Thermography Preliminary Investigations Perfusion Thermography Preliminary Investigations

39 Animations."Fireworks" from Ulead.


Download ppt "Cymatherapy ® Homeodynamics Perfusion Thermography Preliminary Investigations Perfusion Thermography Preliminary Investigations Copyright  2006 Elizabeth."

Similar presentations


Ads by Google